Targeting Glycolytic Adaptations of Cancer Cells: From Molecular Mechanisms to Therapeutic Opportunities

作者: Shanmugasundaram Ganapathy-Kanniappan

DOI: 10.1007/978-94-017-9421-3_15

关键词:

摘要: Metabolic reprogramming is one of the biochemical signatures cancer cells. Particularly, aerobic glycolysis (i.e. process conversion glucose into pyruvate followed by fermentation lactate even in presence oxygen) has been immense interest due to its impact not only on cells but tumor microenvironment as well. Conceptual advancement understanding oncogenic regulation and multifunctional properties glycolytic enzymes underscore relevance significance targeting This chapter will discuss, light recent research intricacies adaptation cells, rationale for exploiting it therapeutic intervention.

参考文章(49)
Gregg L. Semenza, Peter H. Roth, Guang L. Wang, Hon Ming Fang, Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. Journal of Biological Chemistry. ,vol. 269, pp. 23757- 23763 ,(1994) , 10.1016/S0021-9258(17)31580-6
Stephen Yiu Chuen Choi, Colin C Collins, Peter W Gout, Yuzhuo Wang, Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite? The Journal of Pathology. ,vol. 230, pp. 350- 355 ,(2013) , 10.1002/PATH.4218
Laura Novellasdemunt, Laurent Bultot, Anna Manzano, Francesc Ventura, Jose Luis Rosa, Didier Vertommen, Mark H. Rider, Àurea Navarro-Sabate, Ramon Bartrons, PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli. Biochemical Journal. ,vol. 452, pp. 531- 543 ,(2013) , 10.1042/BJ20121886
Robert A. Gatenby, Robert J. Gillies, Glycolysis in cancer: A potential target for therapy The International Journal of Biochemistry & Cell Biology. ,vol. 39, pp. 1358- 1366 ,(2007) , 10.1016/J.BIOCEL.2007.03.021
J. Yun, C. Rago, I. Cheong, R. Pagliarini, P. Angenendt, H. Rajagopalan, K. Schmidt, J. K. V. Willson, S. Markowitz, S. Zhou, L. A. Diaz, V. E. Velculescu, C. Lengauer, K. W. Kinzler, B. Vogelstein, N. Papadopoulos, Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells Science. ,vol. 325, pp. 1555- 1559 ,(2009) , 10.1126/SCIENCE.1174229
L A Pradelli, M Bénéteau, C Chauvin, M A Jacquin, S Marchetti, C Muñoz-Pinedo, P Auberger, M Pende, J-E Ricci, Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation. Oncogene. ,vol. 29, pp. 1641- 1652 ,(2010) , 10.1038/ONC.2009.448
Raymond E. Moellering, Kvar C. Black, Chetan Krishnamurty, Brenda K. Baggett, Phillip Stafford, Matthew Rain, Robert A. Gatenby, Robert J. Gillies, Acid treatment of melanoma cells selects for invasive phenotypes Clinical & Experimental Metastasis. ,vol. 25, pp. 411- 425 ,(2008) , 10.1007/S10585-008-9145-7
Jim Zhong, Narasimhan Rajaram, David M. Brizel, Amy E. Frees, Nirmala Ramanujam, Ines Batinic-Haberle, Mark W. Dewhirst, Radiation induces aerobic glycolysis through reactive oxygen species. Radiotherapy and Oncology. ,vol. 106, pp. 390- 396 ,(2013) , 10.1016/J.RADONC.2013.02.013
Gregg L. Semenza, Tumor metabolism: cancer cells give and take lactate Journal of Clinical Investigation. ,vol. 118, pp. 3835- 3837 ,(2008) , 10.1172/JCI37373
Abdullah Yalcin, Sucheta Telang, Brian Clem, Jason Chesney, Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. Experimental and Molecular Pathology. ,vol. 86, pp. 174- 179 ,(2009) , 10.1016/J.YEXMP.2009.01.003